Trials / Completed
CompletedNCT03007394
Lorcaserin in the Treatment of Cocaine Use Disorder
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 272 (actual)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.
Detailed description
This is a 19-week, multi-center, randomized, Phase 2 clinical study comparing the efficacy of lorcaserin (10mg, b.i.d) to matched placebo in the treatment of cocaine use disorder. Up to 3 weeks will be allowed for the Screening Period and a 13-week treatment phase, with a 3-week follow-up period, with scheduled visits during Study weeks 14 and 16.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lorcaserin | Lorcaserin Capsule |
| DRUG | Placebo Oral Capsule | sugar pill to mimic lorcaserin 10mg capsule |
Timeline
- Start date
- 2017-12-19
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2017-01-02
- Last updated
- 2020-08-05
- Results posted
- 2020-06-19
Locations
12 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03007394. Inclusion in this directory is not an endorsement.